ProFound AI for 2D Mammography Cleared in Europe to Spot Potential Breast Tumors

iCAD, a company based in Nashua, New Hampshire, won European CE Mark approval for its ProFound AI for 2D Mammography software system.

The product relies on a “high-functioning, deep learning” artificial intelligence algorithm to analyze 2D mammography scans and point out potential areas of concern. The software package provides “Certainty of Finding” and “Case Scores” for each instance of a suspect lesion that it identifies, helping radiologists better focus on what’s important while quickening and improving the quality of diagnosis.

The system works by noticing slight changes in soft tissue densities and spotting calcifications, and because the company is working on improving the quality of its algorithm, future updates are expected to further benefit physicians and patients.

“ProFound AI for 2D Mammography has the potential to assist radiologists in their interpretation of 2D mammography images, as we have seen with ProFound AI for Digital Breast Tomosynthesis,” said Axel Gräwingholt, MD, Radiologie am Theater, in Paderborn, Germany. “As breast cancer rates continue to rise, it is imperative for radiologists to find cancers sooner, when they may be more easily treated, with fewer callbacks and false positives, which can be inconvenient and stressful for patients.”

Product page: ProFound AI for 2D Mammography

Via: iCAD

Medgadget Editors

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.